AdaptHealth (NASDAQ:AHCO) Given New $14.00 Price Target at Royal Bank of Canada

AdaptHealth (NASDAQ:AHCO - Get Free Report) had its price target hoisted by equities researchers at Royal Bank of Canada from $11.00 to $14.00 in a research note issued on Wednesday,Benzinga reports. The brokerage currently has an "outperform" rating on the stock. Royal Bank of Canada's price objective points to a potential upside of 23.02% from the company's current price.

Other research analysts have also issued reports about the company. Robert W. Baird reduced their target price on AdaptHealth from $16.00 to $14.00 and set an "outperform" rating on the stock in a research report on Wednesday, November 6th. UBS Group reduced their target price on AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Canaccord Genuity Group reduced their target price on AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research report on Wednesday, November 6th. Finally, Truist Financial boosted their price target on AdaptHealth from $12.00 to $14.00 and gave the company a "buy" rating in a research note on Wednesday. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has an average rating of "Buy" and an average target price of $13.80.

AdaptHealth Stock Up 2.6 %

NASDAQ:AHCO traded up $0.29 during mid-day trading on Wednesday, hitting $11.38. 1,758,793 shares of the company's stock traded hands, compared to its average volume of 1,097,015. The company has a fifty day moving average of $9.92 and a 200 day moving average of $10.23. AdaptHealth has a twelve month low of $8.35 and a twelve month high of $11.90. The company has a market capitalization of $1.53 billion, a P/E ratio of -6.90, a P/E/G ratio of 1.08 and a beta of 1.12. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24.

Institutional Trading of AdaptHealth

Large investors have recently added to or reduced their stakes in the company. Assetmark Inc. purchased a new stake in AdaptHealth during the 4th quarter valued at about $28,000. Blue Trust Inc. boosted its stake in shares of AdaptHealth by 24.1% in the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock worth $55,000 after buying an additional 1,115 shares during the last quarter. Quarry LP boosted its stake in shares of AdaptHealth by 4,596.9% in the third quarter. Quarry LP now owns 5,965 shares of the company's stock worth $67,000 after buying an additional 5,838 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its stake in shares of AdaptHealth by 15.4% in the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock worth $121,000 after buying an additional 1,690 shares during the last quarter. Finally, CIBC Asset Management Inc purchased a new stake in shares of AdaptHealth in the third quarter worth about $122,000. Hedge funds and other institutional investors own 82.67% of the company's stock.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.